. , One of the biggest mistakes I see is assuming that if someone cannot tolerate a GLP 1, there are no other options. Thats Treat to target in weight management with semaglutide: Realworld evidence from an eHealth clinic Seier 2025 Diabetes, Obesity and Metabolism Wiley Online Library An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in patients with obesity with or without type 2 diabetes, a phase II randomized trial showed. Dosing Cagri Peptide : r cagrilintide Eloralintide vs #Cagrilintide Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet